Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (56.145)

41

Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy

enthalten in: Scientific reports | 2024

von Brun, S. | Hansen, T. | Wen, S. | +5

42

An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity

enthalten in: The journal of headache and pain | 2024

von Griffin, E. | Shirley, G. | Lee, X. | +3

43

Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa : a Danish nationwide cohort study

enthalten in: The British journal of dermatology | 2024

von Ring, H. | Thorsen, J. | Kirby, B. | +10

44

Profiling lecanemab as a treatment option for Alzheimer's disease

enthalten in: Expert review of neurotherapeutics | 2024

von Schiller, E. | Silverglate, B. | Grossberg, G.

45

Exposure-efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn's disease and ulcerative colitis

enthalten in: Expert review of clinical pharmacology | 2024

von D'Haens, G. | Rosario, M. | Polhamus, D. | +7

46

Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia

enthalten in: Clinical rheumatology | 2024

von An, Q. | Ma, R. | Yuan, D. | +8

47

Sintilimab and Cardiovascular Toxicity

enthalten in: JAMA | 2024

von Peng, L. | Yang, D. | Weng, C.

CommentOn: JAMA. 2023 Dec 5;330(21):2064-2074. - PMID 38051328

48

Sintilimab and Cardiovascular Toxicity-Reply

enthalten in: JAMA | 2024

von Xu, J. | ORIENT-16 Investigators

CommentOn: JAMA. 2024 Apr 16;331(15):1333-1334. - PMID 38512227

49

In severe eosinophilic asthma controlled with benralizumab, tapering high-dose ICS reduced dose while maintaining control

enthalten in: Annals of internal medicine | 2024

von Stanbrook, M.

50

enthalten in: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG | 2024

von Hansen, I. | Gebhardt, C. | Booken, N. | +1